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Purpose: Landmark indicators have not yet to be developed to detect the regres-
sion of cervical intraepithelial neoplasia (CIN). We propose that quantitative viral 
load and indicative histological criteria can be used to differentiate between atypi-
cal squamous cells of undetermined significance (ASCUS) and a CIN of grade 1. 
Materials and Methods: We collected 115 tissue biopsies from women who test-
ed positive for the human papilloma virus (HPV). Nine morphological parameters 
including nuclear size, perinuclear halo, hyperchromasia, typical koilocyte (TK), 
abortive koilocyte (AK), bi-/multi-nucleation, keratohyaline granules, inflamma-
tion, and dyskeratosis were examined for each case. Correlation analyses, cumula-
tive logistic regression, and binary logistic regression were used to determine opti-
mal cut-off values of HPV copy numbers. The parameters TK, perinuclear halo, 
multi-nucleation, and nuclear size were significantly correlated quantitatively to 
HPV copy number. Results: An HPV loading number of 58.9 and AK number of 
20 were optimal to discriminate between negative and subtle findings in biopsies. 
An HPV loading number of 271.49 and AK of 20 were optimal for discriminating 
between equivocal changes and obvious koilocytosis. Conclusion: We propose 
that a squamous epithelial lesion with AK of >20 and quantitative HPV copy num-
ber between 58.9-271.49 represents a new spectrum of subtle pathological find-
ings, characterized by AK in ASCUS. This can be described as a distinct entity and 
called “regressing koilocytosis”.
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INTRODUCTION
Because infection with the oncogenic human papilloma virus (HPV) represents 
one of the most important risk factors for initiation and progression of cervical car-
cinoma, HPV DNA detection tools have been developed with a triage algorithm 
not only to screen, but also to monitor cervical lesions. In comparison with the tra-
ditional Pap smear, HPV testing is now well known for its high sensitivity and ex-
cellent negative predictive value.1,2
The Hybrid Capture 2 (HC2) assay is a second-generation HPV DNA test that is 
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January 2010 to July 2011. Individuals aged 21-55 years who 
were HPV-positive (HC2-positive) at the first study visit 
and positive more than three times over at least 2 consecu-
tive years, responded to follow up at least three times, had 
no concomitant cancer, had no current referral for a hyster-
ectomy during the subsequent 2 years, and had newly de-
veloped CIN1 or lower diagnosis by biopsy were included. 
Exclusion criteria were known CIN or cancer at baseline, a 
medical history of cervical pathology, HIV infection, or any 
immunosuppressive medication. Based on these criteria, we 
enrolled 115 biopsy samples from HPV-positive patients. 
All participants were monitored for high-risk HPV, using 
HC2 and Pap cytology smears for detecting cervical disease, 
at least three times during the subsequent 2 years. When cer-
vical disease exceeding a low-grade SIL (LSIL) was detect-
ed during follow up, the disease was confirmed by histolog-
ical examination.
Hybrid capture
The HC2 HPV test (Digene; Gaithersburg, MD, USA) was 
performed according to the manufacturer’s instructions to 
detect HPV, using 4 mL of liquid cytology specimens. The 
HC2-13 high-risk probe cocktail detects HPV types 16, 18, 
31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68.4 A relative 
light unit (RLU)/cut-off ratio between 1 and 2.5 RLU was 
used as the threshold for a positive result. The FDA-recom-
mended cut-off value for a positive test result is 1.0 RLU 
(equivalent to 1 pg HPV DNA per 1 mL of sampling buf-
fer). Digitized RLUs are known to be proportional to the 
amount of target DNA present in the specimen, thus pro-
viding a semiquantitative measure of viral load.
Quantitative measurements of the morphological 
criteria
We designed a diagnostic algorithm using the following 
morphological variables in the selected, sharply demarcated 
lesions observed by low-magnification scanning: 1) nuclear 
enlargement to three times the size of adjacent intermediate 
cells; 2) bi- or multi-nucleation; 3) nuclear hyperchromasia; 
4) perinuclear halo (pNcH); 5) typical koilocytes (TKs); 6) 
abortive koilocytes (AKs); 7) keratohyaline granules; 8) in-
flammatory cells interspersed in the epithelium; and 9) 
apoptotic dyskeratosis. For each variable, we examined the 
ratio of positive cells to all observed cells in the selected le-
sion (1, 4-6). Bi- or multi-nucleation (variable 2) was count-
ed as an absolute number of applicable cells in the specific 
selected lesion. Nuclear hyperchromasia, keratohyaline 
especially useful for focusing on about two dozen major, 
high-risk types of HPV.1,3 It has the power to provide viral 
loading concentrations as a score to reflect viral burden in 
terms of replication or proliferation, although it is limited to 
detecting only high-risk groups.4 While even major geno-
types of HPV infection are known to regress spontaneously,5 
host and viral factors, including persistent or multiple infec-
tions, are significantly associated with progressive disease.6,7
As a candidate risk factor, the role of quantitative viral 
load has been debated to be preferentially associated with 
the histological severity of cervical intraepithelial neoplasia 
(CIN).5 In this study, we sought to correlate viral load num-
bers with the cytomorphological spectrum, including the 
vague regressing period of an HPV infection.
Traditionally, cervical cancer has been considered to be a 
multistep progression through CIN, from grades CIN1-3, 
and eventually to stromal invasion.8,9 However, since the 
clarification of HPV-infected koilocytosis, the “squamous 
intraepithelial lesion” (SIL) concept has been newly intro-
duced to replace CIN. Thus, low-grade SIL is now regarded 
as a viral replicative stage and reversible lesion; whereas, 
high-grade SIL may be defined as a proliferative stage and 
a mostly irreversible lesion.10 The CIN2 group is very het-
erogeneous, including stages of both viral replication and 
cellular proliferation, as well as vaguely defined stages.11
Moreover, there is neither a clearly defined spectrum nor 
a specific pathological entity for cases in which HPV-in-
fected cells, which are identified in CIN1, regress as a result 
of an immunological response. It is possible that the many 
cytological findings of atypical squamous cells of undeter-
mined significance (ASCUS) could be compatible with stag-
es of regressing koilocytosis.
Given an ASCUS-matched spectrum (from the Bethesda 
System), pathologists may recognize tissue findings with 
sufficient criteria so that ASCUS does not become a hodge-
podge of ill-defined diagnostic categories. We attempted to 
determine findings from tissue biopsy specimens specific to 
cytological ASCUS and to clarify whether they are byprod-
ucts of an ongoing process of regressive findings following 
initial HPV infection.
MATERIALS AND METHODS
　　　
Study population
Punch biopsy samples were collected at the Department of 
Pathology, Yonsei University College of  Medicine, from 
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keratosis with normal-sized, regular, or spindle-shaped nu-
clei and deep orangeophilic cytoplasm in the specific lesion.12 
Biopsy diagnoses were performed according to the World 
Health Organization classification and coded as follows: 
cervical epithelia within normal limits or chronic inflamma-
tion, 0; regressing koilocytosis focally composed of AKs or 
ASCUS, 1; CIN1, 2; CIN2, 3; CIN3, 4; and squamous cell 
carcinoma, 5. If a lesion showed a mixture of two different 
grades, we used the higher grade. All measurements were 
performed by two gynecologic pathologists in two consec-
utive rounds of assessment. The purpose of the first round 
was to teach and train both pathologists at the same time 
under a shared microscope. The second round was done as 
a double-blind examination. Cases with discrepancy were 
resolved by a third-round of review.
Statistical methods
To assess the correlation between HPV copy number and 
morphological variables, correlation analyses were per-
formed. Linear regression analysis was conducted between 
log (HPV) and the morphological scale values. Additional-
ly, a cumulative logistic regression was performed between 
the biopsy diagnosis (0-5) and each morphological criterion 
with log (HPV). The biopsy scale was also analyzed ac-
cording to focus using binary logistic regression on a nar-
row scale (0-2) or a wide scale (0-5). A correlative analysis 
was conducted using HPV load numbers and quantitative 
cytopathological scales based on different groupings of the 
scales [(0) and (1, 2)] versus [(0, 1) and (2)], to establish the 
dividing criteria between normal, subclinical lesions, and 
CIN1. Among the models derived from the regression anal-
ysis, the best-fit model for the calculation of cut-off values 
was selected based on the lowest Akaike information crite-
rion (AIC) and the highest odds ratio (OR) (Table 1). Cut-
off values were selected based on the priority of large area 
under the curve (AUC), and high positive and negative pre-
dictive values (PPV and NPV, respectively).
We performed a priori adjustment for age at each of the 
nine cytopathological scales and diagnoses based on cytol-
ogy, focusing on subclinical LSIL (ASCUS) versus LSIL.
RESULTS
 
Algorithm considering calculation of cut-off values
In practice, koilocytotic changes can be poorly defined and 
too broad even for experienced pathologists. Therefore, in 
granules, exocytotic inflammatory cells, and dyskeratosis 
were assessed as 3/2/1/0, according to the degree of change 
(with 0 representing no change; 3 representing maximum 
change). Each variable in our algorithm (% size, % pNcH, 
and % TK) used to determine a final score in a specific le-
sion, is defined as described below.
Size (%)=
    No. of enlarged cells     
×100
 
                  Total squamous epithelia
The enlarged cell refers to those with nuclear enlarge-
ment three times the size of adjacent intermediate cells.
pNcH (%)=
 No. of cells containing definite clear zone 
×100
                                   Total squamous epithelia 
TKs were defined when the following three conditions 
were satisfied: 1) size: nuclear enlargement at least three 
times the size of the adjacent intermediate cells; 2) hyper-
chromasia: grade 3; and 3) pNcH: presence of a definite 
clear zone surrounding the nucleus.
TK (%)=
             No. of TKs            
×100
 
                 Total squamous spithelia
AKs were defined as superficial or intermediate cells that 
met only one or two of these conditions, showing some 
perinuclear cytoplasmic clearing, but lacking the large, 
sharply demarcated pNcH surrounded by a condensed cy-
toplasmic rim and nuclear atypia.12,13 The degree of AKs 
was coded according to the total number of AKs in the spe-
cific selected lesion as follows: 0, no AKs; 1, AK is ≥1 but 
<10; 2, AK is ≥10 but <20; 3, AK ≥20.
Nuclear chromatin was coded as either 1, nuclear chro-
matin similar to that of normal cells; 2, slightly increased 
chromatin; 3, definitely coarse chromatin. Bi- or multi-nu-
cleation was counted as the total number of cells containing 
double- or multi-nucleated cells with regular chromatin pat-
tern12 in the specific lesion. Keratohyaline granules were 
defined as basophilic granules mostly around the nucleus, 
resembling nuclear fragmentation,12 and they were coded as 
0/1/2/3 according to the amount of granules in a specific le-
sion, with higher integers representing relatively greater 
numbers of granules. Inflammatory exocytosis was coded 
as 0/1/2/3 according to the number of lymphocytes within 
the epithelium of the specific lesion. Dyskeratosis was cod-
ed as 0/1/2/3 according to the number of cells showing dys-
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the study observations from double-blinded microscopic 
examination of biopsy specimens were used to design a di-
agnostic algorithm covering the spectrum of koilocytotic 
changes to differentiate TKs from AKs. Here, TKs were de-
fined using the following criteria: an acentric, hyperchromat-
ic, and moderately enlarged nucleus that has been displaced 
by a large perinuclear halo. AKs cover a spectrum that did 
not meet all of the criteria of TKs; AKs were assessed ac-
cording to the absolute number of AKs in five high-power 
fields of the selected lesion (Fig. 1). Reactive changes such 
as dyskeratosis, keratohyaline granules, and lymphocytes 
migrating into the epithelium were observed in up to 25%, 
30%, and more than 50% of the cases, respectively.
Using our algorithm, we evaluated cut-off values in sub-
clinical HPV lesions that were compatible with an ASCUS 
finding by cytopathology, as well as with CIN1 (LSIL with 
prominent koilocytosis) by tissue biopsy. Cut-off values 
based on the criteria of a large AUC, and high PPV or NPV 
are presented in Table 2.
Correlation analyses between variables
Correlation analyses between HPV load number and the 
nine morphological criteria were performed. Morphological 
Table 1. Best-Fit Model Selection to Calculate Cut-Off Values between Biopsy Scores of [(0) and (1, 2)], and [(0, 1) and (2)], 
Based on the Lowest AIC and the Highest OR
Variable
Odds ratio estimates
p value AIC
Point estimate 95% wald confidence limits
Selected model 
Log (HPV) 1.354 1.044 1.756 0.0223
92.227AK 0.734 0.413 1.304 0.2913
Age 0.953 0.910 0.999 0.0456
AIC, Akaike information criterion; OR, odds ratio; AK, abortive koilocyte; HPV, human papilloma virus.
Table 2. Selection of Cut-Off Values Based on the Criteria of Large AUC and High PPV, NPV, Sensitivity, and Specificity
Cut-off value for log (HPV) Cut-off value for AK
Biopsy diagnosis scores of (0) and (1, 2)
Estimate Lower limit Upper limit
4.07737
  [exp (4.07737)=58.9]
3 (AK>20)
Sensitivity 72.73 57.53 87.92 
Specificity 48.89 34.28 63.49 
PPV 51.06 36.77 65.36 
NPV 70.97 54.99 86.95 
Accuracy 58.97 48.06 69.89 
Cut-off value for log (HPV) Cut-off value for AK
Biopsy diagnosis scores of (0, 1) and (2)
Estimate Lower limit Upper limit
5.60393 
  [exp (5.60393)=271.49]
3 (AK>20)
Sensitivity 67.86 50.56 85.16
Specificity 68.00 55.07 80.93
PPV 54.29 37.78 70.79
NPV 79.07 66.91 91.23
Accuracy 67.95 57.59 78.31
Biopsy scores: 0, cervical epithelia within normal limits or chronic inflammation; 1, compatible lesions showing regressing koilocytosis or ASCUS; 2, CIN1. 
AK, abortive koilocyte; PPV, positive predictive value; NPV, negative predictive value; AUC, area under the curve; HPV, human papilloma virus.
Fig. 1. Microscopic examination of biopsied specimens: the spectrum of 
koilocytosis is variable between abortive and typical koilocytosis, from the 
diagnosis of CNI, cervical epithelia within normal limits or chronic inflamma-
tion (a), to CIN1, cervical intraepithelial neoplasm 1 (g), depending on wheth-
er the cell meets all the criteria of an acentric, hyperchromatic, moderately 
enlarged nucleus (c) displaced by a large perinuclear halo (f) or multinucle-
ation (e). Other variables such as keratohyaline granules (b) and dyskerato-
sis, presumed to be inflammatory effects (d), were noted occasionally. AK, 
abortive koilocyte; TK, typical koilocyte.
CNI
AK
TKCIN1
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0.3166 (31.7%) indicated that 31.7% of the variability in log 
(HPV) could be explained by differences in TK number and 
size.
Cumulative logistic regression was performed to analyze 
the correlation between biopsy diagnosis scores (0-5; ordinal 
dependent variable) and the nine morphological criteria and 
log (HPV) (independent variable). Among the models ana-
lyzed, the best-fit model compatible with the lowest AIC 
(295.869) showed that factors correlating with an accurate 
diagnosis by tissue biopsy include log (HPV) (OR=1.183; 
p=0.0571), number of AKs (OR=0.629; p=0.0216), nuclear 
size (OR=1.041; p<0.0001), and age (OR=1.015; p=0.2971). 
factors significantly correlated with the HPV quantitative 
copy number included the number of TKs (p<0.0001), de-
gree of pNcH (p<0.0001), multi-nucleation (p=0.0193), and 
nuclear size (p=0.0315). The number of AKs was not corre-
lated with HPV copy number.
We performed a multiple linear regression analysis of log 
(HPV) (dependent variable) against the nine morphological 
criteria (explanatory variables). Among the 12 models ana-
lyzed, model #12, with a combination of two major explana-
tory variables, i.e., the number of TKs and size (nuclear en-
largement), showed the highest adjusted R2 value (0.3166; p 
<0.001) and was the best-fit model. The adjusted R2 value of 
0 0
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Fig. 2. Receiver operating characteristic (ROC) curves of log (HPV), AK, and a priori for age, for discrimination between (A) negative (0) and equivocal find-
ings (1, 2); and (B) equivocal changes (0, 1) and obvious koilocytosis (2) in biopsies. AK, abortive koilocyte; HPV, human papilloma virus.
Fig. 3. Diagnostic algorithm for abnormal squamous cell lesions. Optimal cut-off values for ASCUS: regressing koilocytes matched ASCUS in the quantitative 
HPV copy number over the range of 58.9-271.49 when more than 20 AKs were detected. , the cases which do not meet any of the above three criteria;  , 
the cases which meet only one of the above three criteria; , the cases which meet two of the above three criteria; , the cases which meet all of the 
above three criteria. ASCUS, atypical squamous cells of undetermined significance; AK, abortive koilocyte; TK, typical koilocyte; HC, hybrid capture; CNI, 
cervical epithelia within normal limits or chronic inflammation; CIN1, cervical intraepithelial neoplasm 1; LR HPV, low risk human papilloma virus.
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harbored in cells/tissues subclinically at and beyond the ap-
parently normal margins of many active, visible lesions, 
and in patients in remission.17
Replication of HPV in epithelial cells is accompanied by 
morphological cell alterations, resulting in pathogenic ef-
fects characteristic of HPV infection, allowing for morpho-
logical diagnosis of clinical HPV infections in Pap smears 
and biopsies with a high degree of accuracy.16 Koilocytes 
are squamous epithelial cells with an acentric, hyperchro-
matic nucleus that are displaced by a large pNcH as well as 
occasional multi-nucleation.18-20 However, given the evolv-
ing mechanisms and biology of HPV, cytopathological 
classification remains at a conventional stage and has failed 
to keep pace with the virology. Using only initially defined 
TKs, pathologists encounter a diagnostic conundrum. Over 
70-90% of patients with HPV infection regress spontane-
ously. However, diagnostic criteria are too variable to as-
sess and unify the changes in regression. This study was de-
signed to clarify whether specific findings matching with 
ASCUS exist in subsequent biopsied tissues, and to deter-
mine if they are byproducts of the regressive process follow-
ing initial HPV infection. To accomplish this, categorization 
of microscopic findings and a comparative tool based on 
reference values are essential prerequisites. Nine major find-
ings and five groups of diagnoses with reference values of 
log (HPV) copy numbers were determined here.
As an additional challenge, numerous clinical cases in-
clude AKs that could also be classified as TK.21 AKs are fre-
quently observed, but they are vaguely defined and seldom 
standardized. We suggest that the definition of AKs include 
the presence of superficial or intermediate cells meeting 
only one or two of the following criteria: 1) nuclear enlarge-
ment at three times the size of the adjacent intermediate 
cells; 2) hyperchromasia; and 3) pNcH. Whether the pres-
ence of HPV in AKs corresponds to an established infec-
tion is still debated.
In the present study, we found that HPV loading number 
(copy burden) significantly correlates with the number of 
TKs, degree of pNcH, multi-nucleation, and nuclear size. 
Because the number of AKs failed to show a correlation 
with HPV copy number, we suggest that cells indicative of 
AKs, whether early or late in the process, have lost the ca-
pacity to replicate virions. Moreover, well known support-
ive findings in characterizing koilocytes, including dyskera-
tosis and keratohyaline granules, do not correlate with HPV 
copy number. This indicates that both findings are not di-
rect signs of active replication of virions, but rather residual 
These results indicate that higher HPV copy number, lower 
AKs frequency, greater nuclear size, and increased age re-
sult in a greater chance of HPV diagnosis by tissue biopsy. 
In all the models, number of TKs was the variable showing 
most significant correlation with HPV load (p<0.001).
Binary logistic regression to calculate cut-off values
Subsets of binary logistic regression were limited to biopsy 
diagnosis scores of 0-2 as the dependent variable. To deter-
mine the best-fit model, we selected the model with log 
(HPV) and AKs as independent variables showing the low-
est AIC (92.227) and highest OR [log (HPV)=13.54] (Table 
1) to calculate the cut-off values and receiver operating 
characteristic curves between biopsy scores [(0) and (1, 2)], 
and [(0, 1) and (2)]. In the selected model, HPV cut-off val-
ues of 58.9 and 271.49 were selected for biopsy scores [(0) 
and (1, 2)], and [(0, 1) and (2)], respectively, on the basis of 
maximizing AUC (Fig. 2). Fig. 3 summarizes the diagnos-
tic algorithm using morphological scales in addition to the 
HC2 value. Load values of HPV above 58.9 and AK num-
bers above 20 were the optimal cut-off values to discrimi-
nate between negative findings (biopsy score 0) and equiv-
ocal changes (biopsy scores 1 and 2). Viral load above 
271.49 and AK numbers >20 were the optimal cut-off val-
ues to discriminate between equivocal changes (biopsy 
scores 0 and 1) and obvious koilocytosis (biopsy score 2). 
Binary logistic regression, considering the wide range of 
the CIN spectrum as a dependent variable, was also per-
formed. In cases where more than one-third of the cells 
showed increased size, an HPV load greater than 56.85 was 
the optimal cut-off value to discriminate between a subclin-
ical diagnosis of undetermined significance (biopsy scores 
0 and 1) and obvious clinical lesions (biopsy scores 2-5).
DISCUSSION
Commonly, HPV infects the nuclei of mitotically active bas-
al cells in the epithelium, thus establishing an infective cy-
cle. Spontaneous regression of HPV infection has been ob-
served in 71.1% of one cohort.14 Patients who fail to clear 
the virus and remain persistently infected are at risk of pro-
gression to grade 2/3 CIN, the obligate precursor to inva-
sive cervical cancer.15 It is known that HPV infection may 
result in latent, subclinical, and clinical infections.16 Latent 
infections have been difficult to examine because concen-
trations of viral DNA and RNA are low, and HPV may be 
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CNI. Finally, when the lesion has more than 20 AKs, with 
HPV copy numbers in the range of 58.9 to 271.49, we sug-
gest it is reasonable to give these lesions an independent di-
agnosis of “regressing koilocytosis”, in both the biological 
and pathological sense. The diagnostic term “regressing 
koilocytosis” can describe the infectious status of HPV, and 
it denotes the presumptive direction or fate of infection. Be-
cause it is based on the HPV loading number, this makes 
the lesional status clearer to communicate with clinicians 
for case management. To summarize, regressing koilocyto-
sis can be narrowly defined as a squamous epithelial lesion, 
whether sharply or vaguely defined, with more than 20 
AKs and with HPV copy numbers in the range of 58.9 to 
271.49.
In conclusion, equivocal pathological findings character-
ized by AKs are compatible with ASCUS, or regressing 
koilocytosis, and they can be correlated with HPV load us-
ing optimal cut-off values.
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